Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Top Story
Concussion
Danaher launches collaboration with Johns Hopkins University on TBI diagnostics
Danaher has launched a partnership with Johns Hopkins University aimed at developing new traumatic brain injury (TBI) diagnostics.
Featured
PCR
Qiagen partners with FBI on forensics assay
Immunoassays
University of Florida researchers develop CRISPR-based assay for HPV detection
Latest News
Geneoscopy receives FDA approval for CRC screening test
May 7, 2024
German court rules patent invalid in 10x infringement suit against NanoString
May 8, 2024
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Cue Health to cut 230 jobs in restructuring plan
May 3, 2024
Business Insights
Mergers & Acquisitions
Myriad Genetics reorganizes EU operations, sells EndoPredict business
FDA Clearance
Geneoscopy receives FDA approval for CRC screening test
Lawsuit
German court rules patent invalid in 10x infringement suit against NanoString
Financing
Karius raises $100M in series C funding
Diagnostic Technologies
PCR
Qiagen partners with FBI on forensics assay
Immunoassays
University of Florida researchers develop CRISPR-based assay for HPV detection
Financing
Karius raises $100M in series C funding
Diagnostic Technologies
FDA said no to proficiency testing for LDT quality
Diseases
Concussion
Danaher launches collaboration with Johns Hopkins University on TBI diagnostics
Immunoassays
University of Florida researchers develop CRISPR-based assay for HPV detection
FDA Clearance
Geneoscopy receives FDA approval for CRC screening test
Collaboration
Astellas and Poseida to collaborate on oncology cell therapies
More from LabPulse.com
Myriad Genetics reorganizes EU operations, sells EndoPredict business
By
LabPulse.com staff writers
Precision medicine company Myriad Genetics has signed an agreement to sell its EndoPredict business to French IVD and life sciences firm Eurobio Scientific.
May 9, 2024
Karius raises $100M in series C funding
By
LabPulse.com staff writers
Diagnostics firm Karius has secured $100 million in series C funding in a recent financing round.
May 6, 2024
Novo Nordisk Foundation, Wellcome, Gates Foundation to partner on global health challenges
By
LabPulse.com staff writers
The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have announced a collaboration to support scientific research and development for accessible solutions to global health challenges.
May 6, 2024
Leica Biosystems, Sectra receive FDA 510(k) clearance for digital pathology system
By
LabPulse.com staff writers
Leica Biosystems has received 510(k) clearance from the U.S Food and Drug Administration (FDA) for its Aperio GT 450 DX digital pathology system, in conjunction with Sectra's digital pathology software.
May 2, 2024
Quest Diagnostics to add digital pathology lab, AI pathology center in Tennessee
By
LabPulse.com staff writers
Quest Diagnostics said it will acquire PathAI Diagnostics in Memphis, TN, the business of PathAI that provides anatomic and digital pathology laboratory services, to accelerate the adoption of digital and AI pathology.
May 1, 2024
Astellas and Poseida to collaborate on oncology cell therapies
By
LabPulse.com staff writers
Poseida Therapeutics and Astellas, under its Xyphos Biosciences subsidiary, have initiated a research collaboration and licensing agreement to develop allogeneic cell therapy programs by combining their innovative cell therapy platforms and technologies.
May 2, 2024
FDA releases LDT final rule
By
Liz Carey
The FDA announced its final rule on regulating laboratory developed tests (LDTs), also saying it will adopt targeted enforcement discretion for several categories of IVD LDTs manufactured by labs.
April 29, 2024
GSK, Genomics PLC collaborate on polygenic risk score use for clinical trials
By
LabPulse.com staff writers
Genomics PLC and biopharmaceutical firm GSK have established a collaboration aimed at assessing the potential for using polygenic risk scores in clinical trials.
May 1, 2024
Variantyx raises $36M in funding
By
LabPulse.com staff writers
Precision molecular diagnostics firm Variantyx has raised $36 million in a recent funding round, bringing the total funding that Variantyx has raised to more than $125 million.
April 30, 2024
Study: Age-related differences in nasal cells offer COVID-19 protection
By
Matt Limb
Key differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus may explain why children typically experience milder symptoms of COVID-19, say researchers.
April 29, 2024
Pillar Biosciences gets FDA approval for NGS solid tumor profiling test
By
Matt Limb
Pillar Biosciences has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its OncoReveal CDx pan-cancer next-generation sequencing (NGS) test for general solid tumor profiling.
April 26, 2024
Immunovia announces positive results for next-gen pancreatic cancer test
By
LabPulse.com staff writers
Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.
April 25, 2024